BridgeMD
Compares treatment options for Depression
Official title Group-Based Acceptance and Commitment Therapy Versus Active Control in University Students With Emotional Symptoms
ClinicalTrials.gov ID: NCT07506148
What this study is testing
- What it's testing
- This study evaluates the efficacy of a group-based Acceptance and Commitment Therapy (ACT) protocol compared to a non-directive group therapy used as an active control condition in university students presenting moderate to moderate/high levels of emotional symptomatology. Emotional difficulties such as depressive and anxiety symptoms are highly prevalent among university students and may negatively affect academic performance, well-being, and long-term functioning.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 28
You may be able to join if
- University students aged 18 to 28 years.
- Score ≥8 on the PHQ-9.
- Score ≥8 on the GAD-7.
- Willingness to participate in a longitudinal study including pre-, post-, and follow-up assessments.
- Willingness to complete daily and weekly ecological momentary assessments (EMA).
You likely can't join if
- Suicide risk based on clinical indicators derived from PHQ-9 assessment.
- Self-reported history of psychotic disorders.
- Self-reported problematic substance use.
- Failure to provide informed consent.
See the full eligibility criteria
- University students aged 18 to 28 years.
- Score ≥8 on the PHQ-9.
- Score ≥8 on the GAD-7.
- Willingness to participate in a longitudinal study including pre-, post-, and follow-up assessments.
- Willingness to complete daily and weekly ecological momentary assessments (EMA).
- Provision of written informed consent.
- Suicide risk based on clinical indicators derived from PHQ-9 assessment.
- Self-reported history of psychotic disorders.
- Self-reported problematic substance use.
- Failure to provide informed consent.
The study team makes the final eligibility decision.
Where it's taking place
- Montevideo, Montevideo Department, Uruguay
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 28 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Montevideo, Montevideo Department, Uruguay. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.